Kenzen, a developer of a next-generation wearables platform that continuously monitors, predicts and prevents avoidable health conditions using non-invasive sweat analysis has raised $5 million in funding. The round’s strategic investors include Digitalis, Flex (formerly Flextronics), the San Francisco 49ers, Hickory Ventures, Gaingels, and the Women’s Capital Connection. The company plans to utilize the funding to expand further development, support and market positioning of its ECHO Smart
Read More
Impact of Precision Medicine| News, Policy, Analysis, Insights - HIT Consultant
Northwestern, Tempus Expand Partnership to Accelerate Personalizing Care for Cancer Patients
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University is expanding its partnership with Tempus aimed at personalizing care for cancer patients. Tempus provides molecular sequencing and clinical analytic solutions for top academic centers, hospital systems, associations, and healthcare providers.As part of the expanded collaboration, Tempus will provide molecular sequencing and analysis for patient derived xenograft (PDX) models and patient derived organoid models, which will
Read More
Precision Medicine Startup AltheaDx Lands $27M to Expand Personalized Therapeutic Decisions Internationally
AltheaDx, Inc., a San Diego, CA-based commercial stage molecular diagnostics company specializing in the field of personalized medicine has raised $27 million in Series D funding. The company is a CAP-accredited, CLIA-certified laboratory and plans to utilize the funding to expands its sales force and marketing efforts to grow internationally.IDgenetix, the company’s product testing portfolio, enables personalized therapeutic decisions for patients suffering from some of the most prevalent
Read More
Aurora Cancer Care Launches Precision Medicine Program To Help Patients Gain More Access to Clinical Trials
Aurora Cancer Care, a not-for-profit health care provider in Wisconsin and northern Illinois is launching a precision medicine program powered by Syapse, a provider of precision oncology solutions. The new oncology precision medicine program will help physicians and researchers provide more care options for patients whose cancer is resistant to conventional treatment options like radiation and chemotherapy.The new multi-disciplinary Oncology Precision Medicine Clinic will be located inside
Read More
Aprima EHR Integrates With ActX to Bring Precision Medicine Into The Physician’s Office
Aprima, a physician pratice-focused EHR provider has announced an integration partnership with Genomic Decision Support platform ActX to bring precision medicine into the physician’s office. The addition of the ActX platform provides Aprima clients with access to genomics in everyday patient care and delivers clinically actionable insights that facilitate personalized medication and screening choices based on a patient’s unique genetic profile.Imagine, during your office visit, your physician
Read More
HL7 Publishes Domain Analysis Model for Clinical Sequencing: 5 Things to Know
Health Level Seven® International (HL7), an authority for health IT interoperability and provider of the Fast Healthcare Interoperability Resources (FHIR) standard, today announced that it has published the HL7 Domain Analysis Model: Clinical Sequencing, a model which captures precision medicine’s use cases to facilitate interoperability of genetic and genomic data. Here are five things to know about the new model: 1. . This domain analysis model (DAM) was the basis for the design of FHIR
Read More
Sweat Is The New Blood: Why Sweat Analysis Is The Next-Gen of Wearable Diagnostics
Editor's Note: Dr. Sonia Sousa is CEO and Co-Founder of Kenzen, a startup that creates next-gen wearable diagnostics based on sweat analysis. Dr. Sousa founded several companies and has over 15 issued and pending patents in the US and worldwide (in photonics, predictive models, lasers, spectroscopy and more). With a PhD in Photonics and Neural Networks, Dr. Sousa is committed to advancing precision medicine and preventing health issues through wearable diagnostics that are clinically relevant,
Read More
Novartis Selects Cota Healthcare’s Data Analytics Platform to Develop Therapies for Breast Cancer Patients
Novartis Pharmaceuticals Corporation has signed a multi-year agreement with Cota Healthcare, a data and technology platform for value-based precision medicine to help improve clinical and cost outcomes for breast cancer patients. As part of this multi-year agreement, Novartis will leverage Cota's research-grade, real-world evidence, web-based analysis and visualization tools, and be supported by Cota's medical, data science, and technology experts. Utilizing the real-world evidence and
Read More
NTT Data, Oracle Collaborate to Bring Healthcare Big Data to the Cloud
NTT DATA, Inc. announced the expansion of its existing relationship with Oracle to include end-to-end cloud capabilities for Oracle’s Healthcare Foundation, a unified healthcare analytics platform. The platform provides data integration and warehousing of clinical, financial, administrative and -omics modules in a cloud solution to customers worldwide. The healthcare cloud offering will provide organizations the ability to easily unify, grow or replace their existing healthcare data warehouse
Read More
3 Keys to Achieving Clinically Actionable Precision Medicine for Providers
Oracle’s Jonathan Sheldon shares his perspective on precision medicine and explains how providers can prepare for the transformation that lies ahead.The term personalized healthcare may seem like a buzzword, but it’s real and developing faster than imagined in the form of precision medicine. Using a patient’s genetic profile in conjunction with lifestyle and environmental variables to create individual treatment plans—what could be more personal than that?Thanks to technology, we are starting to
Read More
